Lapatinib ditosylate Good Manufacturer supply High Quality 388082-78-8
- Molecular Formula:C29H26ClFN4O4S.2(C7H8O3S).H2O
- Molecular Weight:925.477
- Appearance/Colour:colourless to light-yellow crystal
- Melting Point:237 - 239 °C
- Boiling Point:750.7 °C at 760 mmHg
- Flash Point:407.8 °C
- PSA：249.46000
- Density:1.381 g/cm3
- LogP:12.26450
Lapatinib ditosylate (388082-78-8) Usage
Lapatinib ditosylate, also known as Lapatinib I, is an orally active drug primarily used in the treatment of breast cancer. It functions as a dual EGFR (ErbB-1) and ErbB-2 (HER2) inhibitor, targeting the ATP-binding site of these receptor tyrosine kinases (TKs) and preventing their phosphorylation and subsequent activation of other kinase enzymes. Lapatinib is available in 250-mg tablets for oral administration and is often used in combination with capecitabine for patients overexpressing the type 2 EGF-R (HER2 or ErbB-2) who have previously received taxane, anthracycline, and trastuzumab therapy.
How to get the best price on Lapatinib ditosylate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Lapatinib ditosylate . You can buy high quality, low price Lapatinib ditosylate 388082-78-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
